Cited by 249Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic ControlVestibular and auditory disorders

Midodrine: a role in the management of neurocardiogenic syncope

Open access
Ward, C R, Gray, J C, Gilroy, J J, Kenny, R A·1998·Heart

Abstract

Objective: To determine the benefit of midodrine, an α agonist, on symptom frequency and haemodynamic responses during head up tilt in patients with neurocardiogenic syncope. Setting: Cardiovascular investigation unit (a secondary and tertiary referral centre for the investigation and management of syncope). Patients: 16 outpatients (mean (SD) age 56 (18) years; five men) with frequent hypotensive symptoms (more than two syncopal episodes and fewer than 20 symptom free days per month), and reproducible syncope with glyceryl trinitrate (GTN) during head up tilt. Design and intervention: Randomised double blind placebo controlled study. Patients were randomised to receive either placebo or midodrine for one month. Symptom events were recorded during each study month. At the end of each study month patients completed a quality of life scoring scale (Short Form 36) and a global assessment of therapeutic response. They received GTN with head up tilt for measurement of heart rate (electrocardiography), phasic blood pressure (digital photoplethysmography), and thoracic fluid index (transthoracic impedance plethysmography) during symptom provocation. Results: Patients administered midodrine had an average of 7.3 more symptom free days than those who received placebo (95% confidence interval (CI) 4.6 to 9; p < 0.0001). Eleven patients reported a positive therapeutic response with midodrine (p = 0.002). All domains of quality of life showed improvement with midodrine, in particular physical function (8.1; 95% CI 3.7 to 12.2), energy and vitality (14.6; 95% CI 7.3 to 22.1), and change in health status (22.2; 95% CI 11 to 33.4 ). Fourteen patients who were given placebo had tilt induced syncope compared with six given midodrine (p = 0.01). Baseline supine systolic blood pressure was higher and heart rate lower in patients who received midodrine than in those who were given placebo ( p < 0.05). A lower thoracic fluid index in patients administered midodrine indicates increased venous return when supine and during head up tilt. There were no serious adverse effects. Conclusions: Midodrine had a conspicuous beneficial effect on symptom frequency, symptoms during head up tilt, and quality of life. Midodrine is recommended for the treatment of neurocardiogenic syncope in patients with frequent symptoms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/hrt.79.1.45

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • None of the midodrine studies were conventional placebo-controlled randomized clinical trials of moderately to severely symptomatic patients.

    “None of the studies were conventional, placebo-controlled, randomized clinical trials of moderately to severely symptomatic patients.125–128”

    From 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope (2015) · cites this paper as [127]

    The Patients and methods section describes a randomized, double-blind, placebo-controlled midodrine trial, contrary to the claim that none of the cited studies had those features. The Abstract describes participants with frequent symptoms—more than two syncopal episodes and fewer than 20 symptom-free days per month. The trial used a crossover design, so it was not a conventional parallel-group trial, but the source does not support the blanket characterization. (LLM, conf=0.84)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Four randomized trials of midodrine have shown a consistent risk reduction of approximately 70%.

    “Four randomized trials on midodrine have shown a consistent risk reduction of approximately 70%.”

    From 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope (2015) · cites this paper as [127]

    The Patients and methods section describes one randomized crossover trial, not four trials. The Results report fewer tilt-induced syncopal episodes with midodrine; the reported counts of 14 on placebo versus 6 on midodrine correspond to an approximately 57% reduction, not a consistent reduction of approximately 70% across trials. Page numbers are unavailable in our copy. (LLM, conf=0.91)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [1]1. Abi-Samra F, Malony JD, Fouad-Tarazi FM, et al. The use- fulness of head-up tilt testing and haemodynamic investiga- tion in the work up of syncope of unknown origin. PACE 1988;11:1202-14.
  2. [10]10. McIntosh S, Lawson J, da Costa D, et al. Use of sublingual glyceryl trinitrate during head-up tilt: a provocative test for reproduction of neurocardiogenic symptoms in unex- plained syncope. Cardiology in the Elderly 1996;4:33-7.
  3. [15]15. Imholz BPM, Settels JJ, van den Meiracker AH, et al. Non- invasive beat to beat finger blood pressure measurement during orthostatic stress compared to intraarterial pres- sure. Cardiovasc Res 1990;24:214-21.
  4. [24]24. Fitzpatrick A, Ahmed R, Williams S, et al. A randomised trial of medical therapy in "malignant vasovagal syndrome" or "neurally-mediated bradycardia/hypotension syn- drome". European Journal of Cardiac Pacing and Electro- physiology 1991;2:99-102.
  5. [30]30. Natale A, Sra J, Dhala A, et al. EYcacy of diVerent treatment strategies for neurocardiogenic syncope. PACE 1995;18: 655-62.
  6. [34]34. Erhringer H. Studies on the peripheral haemodynamics in man after intravenous infusion of a small dose of di-1-(2',5'-dimethoxyphenyl)-2-glycinamido-ethanol-(1)- hydrochloride. Int J Clin Pharmacol Ther Toxicol 1971;4: 415-20.

Cited by

Sorted by citations

Authors
Ward, C. R., Gray, J. C., Gilroy, J. J., & Kenny, R. A.
Affiliations
Royal Victoria Infirmary (GB)
Corresponding author
Kenny, R A
Venue
Heart
Publisher
BMJ
Published
1998-01-01
Volume
79
Issue
1
Pages
45-49
ISSN
  • 1355-6037 (ISSN-L)
  • 1468-201X
OpenAlex
W2120769605
Cited by
249
References
34
Citations by year
2025: 4 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 10 · 2020: 1 · 2019: 4 · 2018: 4 · 2017: 9 · 2016: 7 · 2015: 5 · 2014: 15 · 2013: 7 · 2012: 9
FWCI
16.68
Type
journal article
Language
en
Open access
Locations
  • Heart (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
Keywords
midodrine, vasovagal syncope, orthostatic intolerance, alpha-adrenergic agonists, head-up tilt, nitroglycerin, symptom frequency, quality of life, venous return, blood pressure, heart rate, adverse effects, treatment response assessment
MeSH terms
Adrenergic alpha-Agonists, Blood Pressure, Cardiography, Impedance, Double-Blind Method, Female, Heart Rate, Humans, Male, Middle Aged, Midodrine, Cross-Over Studies, Tilt-Table Test, Syncope, Vasovagal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review